WO2023285581 - SODIUM N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLATE POLYMORPHIC FORM A
National phase entry:
Publication Number
WO/2023/285581
Publication Date
19.01.2023
International Application No.
PCT/EP2022/069705
International Filing Date
14.07.2022
Title **
[English]
SODIUM N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLATE POLYMORPHIC FORM A
[French]
FORME POLYMORPHE A DE N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLATE SODIQUE
Applicants **
NOVO NORDISK A/S
Novo Allé
2880 Bagsværd, DK
Inventors
VILHELMSEN, Thomas, Kvistgaard
Novo Allé
2880 Bagsværd, DK
DAMHOLT, Zacharias, Brimnes, Visby
Novo Allé
2880 Bagsværd, DK
Priority Data
21186179.4
16.07.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1270 | |
| EPO | Filing, Examination | 5277 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 5110 |
Total: 12821 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to a method of making sodium N-(8-2-Hydroxybenzoyl)amino caprylate form A, SNAC polymorphic form A having improved stability and the use of said SNAC polymorphic form A in a solid pharmaceutical dosage form-[French]
La présente invention concerne un procédé de fabrication d'une forme A de N-(8-2-hydroxybenzoyl)amino caprylate sodique, une forme polymorphe 1 de SNAC ayant une stabilité améliorée et l'utilisation de ladite forme polymorphe A de SNAC dans une forme posologique pharmaceutique solide.